Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to seasonal influenza vaccine and relationship to cytomegalovirus-associated immunosenescence in older UK adults
2006-006563-23Phase 4Terminated
- Sponsor
- Health Protection Agency
- Start
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fluarix in influenza, sponsored by Health Protection Agency. Primary endpoints: Influenza antibody geometric mean titres by CMV serostatus and Level of IgG antibodies against human cytomegalovirus. Started Jan 2007; status: terminated.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-006563-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006563-23.